140 related articles for article (PubMed ID: 36648309)
41. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.
Lee C; Cui Y; Song J; Li S; Zhang F; Wu M; Li L; Hu D; Chen H
Lipids Health Dis; 2019 Apr; 18(1):95. PubMed ID: 30971288
[TBL] [Abstract][Full Text] [Related]
42. Improvement of Definite Diagnosis of Familial Hypercholesterolemia Using an Expanding Genetic Analysis.
Cao YX; Sun D; Liu HH; Jin JL; Li S; Guo YL; Wu NQ; Zhu CG; Liu G; Dong Q; Sun J; Chen XH; Li JJ
JACC Asia; 2021 Jun; 1(1):82-89. PubMed ID: 36338372
[TBL] [Abstract][Full Text] [Related]
43. Heterozygous familial hypercholesterolaemia in a pair of identical twins: a case report and updated review.
Mohd Nor NS; Al-Khateeb AM; Chua YA; Mohd Kasim NA; Mohd Nawawi H
BMC Pediatr; 2019 Apr; 19(1):106. PubMed ID: 30975109
[TBL] [Abstract][Full Text] [Related]
44. Next-generation sequencing to confirm clinical familial hypercholesterolemia.
Reeskamp LF; Tromp TR; Defesche JC; Grefhorst A; Stroes ESG; Hovingh GK; Zuurbier L
Eur J Prev Cardiol; 2021 Jul; 28(8):875-883. PubMed ID: 34298557
[TBL] [Abstract][Full Text] [Related]
45. Predicted pathogenic mutations in STAP1 are not associated with clinically defined familial hypercholesterolemia.
Lamiquiz-Moneo I; Restrepo-Córdoba MA; Mateo-Gallego R; Bea AM; Del Pino Alberiche-Ruano M; García-Pavía P; Cenarro A; Martín C; Civeira F; Sánchez-Hernández RM
Atherosclerosis; 2020 Jan; 292():143-151. PubMed ID: 31809983
[TBL] [Abstract][Full Text] [Related]
46. The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia.
Hori M; Takahashi A; Son C; Ogura M; Harada-Shiba M
Lipids Health Dis; 2020 Apr; 19(1):62. PubMed ID: 32252761
[TBL] [Abstract][Full Text] [Related]
47. Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis.
Di Taranto MD; Fortunato G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834635
[TBL] [Abstract][Full Text] [Related]
48. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
Bourbon M; Rato Q;
Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
[TBL] [Abstract][Full Text] [Related]
49. Unusual genetic variants associated with hypercholesterolemia in Argentina.
Corral P; Geller AS; Polisecki EY; Lopez GI; Bañares VG; Cacciagiu L; Berg G; Hegele RA; Schaefer EJ; Schreier LE
Atherosclerosis; 2018 Oct; 277():256-261. PubMed ID: 30270055
[TBL] [Abstract][Full Text] [Related]
50. The island of Gran Canaria: A genetic isolate for familial hypercholesterolemia.
Sánchez-Hernández RM; Tugores A; Nóvoa FJ; Brito-Casillas Y; Expósito-Montesdeoca AB; Garay P; Bea AM; Riaño M; Pocovi M; Civeira F; Wägner AM; Boronat M
J Clin Lipidol; 2019; 13(4):618-626. PubMed ID: 31153816
[TBL] [Abstract][Full Text] [Related]
51. Array-based resequencing for mutations causing familial hypercholesterolemia.
Chiou KR; Charng MJ; Chang HM
Atherosclerosis; 2011 Jun; 216(2):383-9. PubMed ID: 21376320
[TBL] [Abstract][Full Text] [Related]
52. The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population.
Fairoozy RH; Futema M; Vakili R; Abbaszadegan MR; Hosseini S; Aminzadeh M; Zaeri H; Mobini M; Humphries SE; Sahebkar A
Sci Rep; 2017 Dec; 7(1):17087. PubMed ID: 29213121
[TBL] [Abstract][Full Text] [Related]
53. Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation.
Mabuchi H; Nohara A; Noguchi T; Kobayashi J; Kawashiri MA; Inoue T; Mori M; Tada H; Nakanishi C; Yagi K; Yamagishi M; Ueda K; Takegoshi T; Miyamoto S; Inazu A; Koizumi J;
Atherosclerosis; 2014 Sep; 236(1):54-61. PubMed ID: 25014035
[TBL] [Abstract][Full Text] [Related]
54. Phenotype of definite familial hypercholesterolemia with negative genetic study in Argentina.
Corral P; Bañares V; Sáenz B; Zago V; Sarobe A; López G; Berg G; Schreier L
Arch Cardiol Mex; 2020; 90(2):130-136. PubMed ID: 32897268
[TBL] [Abstract][Full Text] [Related]
55. Spectrum of mutations of familial hypercholesterolemia in the 22 Arab countries.
Alhababi D; Zayed H
Atherosclerosis; 2018 Dec; 279():62-72. PubMed ID: 30415195
[TBL] [Abstract][Full Text] [Related]
56. Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients.
Hori M; Ohta N; Takahashi A; Masuda H; Isoda R; Yamamoto S; Son C; Ogura M; Hosoda K; Miyamoto Y; Harada-Shiba M
Atherosclerosis; 2019 Oct; 289():101-108. PubMed ID: 31491741
[TBL] [Abstract][Full Text] [Related]
57. Genetic diagnosis of familial hypercholesterolaemia by targeted next-generation sequencing.
Maglio C; Mancina RM; Motta BM; Stef M; Pirazzi C; Palacios L; Askaryar N; Borén J; Wiklund O; Romeo S
J Intern Med; 2014 Oct; 276(4):396-403. PubMed ID: 24785115
[TBL] [Abstract][Full Text] [Related]
58. Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia.
Ohta N; Hori M; Takahashi A; Ogura M; Makino H; Tamanaha T; Fujiyama H; Miyamoto Y; Harada-Shiba M
J Clin Lipidol; 2016; 10(3):547-555.e5. PubMed ID: 27206942
[TBL] [Abstract][Full Text] [Related]
59. Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia.
Benedek P; Jiao H; Duvefelt K; Skoog T; Linde M; Kiviluoma P; Kere J; Eriksson M; Angelin B
J Intern Med; 2021 Aug; 290(2):404-415. PubMed ID: 33955087
[TBL] [Abstract][Full Text] [Related]
60. Global molecular analysis and APOE mutations in a cohort of autosomal dominant hypercholesterolemia patients in France.
Wintjens R; Bozon D; Belabbas K; MBou F; Girardet JP; Tounian P; Jolly M; Boccara F; Cohen A; Karsenty A; Dubern B; Carel JC; Azar-Kolakez A; Feillet F; Labarthe F; Gorsky AM; Horovitz A; Tamarindi C; Kieffer P; Lienhardt A; Lascols O; Di Filippo M; Dufernez F
J Lipid Res; 2016 Mar; 57(3):482-91. PubMed ID: 26802169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
